← Leaderboards
Margaret Axelrod
Vanderbilt University
$132,727
Attributed
$132,727
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$132,727 · 1
By mechanism
F30$132,727 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nipun B. Merchant$6,490,068
- Sebastian Joyce$13,492,547
- Justin M Balko$6,825,551
- Brian W Christman$2,794,423
- David H Zald$14,412,158
Others in their field
Other Emerging Leaders on “Antigen-Presenting Cells”
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$6,865,597
- Guizhi Zhu · Virginia Commonwealth University$4,585,902
- Krystalyn E Hudson · Bloodworks$4,506,759
- Duygu Ucar · Jackson Laboratory$3,828,781
- Alice Oliffson Kamphorst · Icahn School Of Medicine At Mount Sinai$3,798,372
- Lucia N Vojtech · University Of Washington$3,568,831
Research focus
Antigen-Presenting CellsAntigensAnti-Tumor Immune ResponseAutologousAutologous Dendritic CellsAutologous Tumor CellBaseBindingCancer TherapyCd4 Positive T LymphocytesCd80 GeneCd8 AntigensCd8-Positive T-LymphocytesCell LineCellsCell SurfaceCell TypeCellular TransductionCheckpoint InhibitionClinicCoculture TechniquesCytokineCytometryAnimals
Grant awards (3)
Modulation of the anti-tumor immune response by Major Histocompatibility Class-II expression on tumor cells$51,036
F30 · FY2021 · CA · contact PI
Modulation of the anti-tumor immune response by Major Histocompatibility Class-II expression on tumor cells$49,775
F30 · FY2020 · CA · contact PI
Modulation of the anti-tumor immune response by Major Histocompatibility Class-II expression on tumor cells$31,916
F30 · FY2019 · CA · contact PI